Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures.
Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures. The company's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform. These products enable physicians to perform better, faster, and safer vascular occlusion procedures.The company was founded in 2011 and is based in Olathe, Kansas.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 8, 2018 | Grant | $1.50M | 1 | National Institutes of Health | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |